From: Study on the HIV drug resistance and its influencing factors in China
 |  |  |  | Drug resistance |  | |||
---|---|---|---|---|---|---|---|---|
Group | Drug | No. | Sensitive (%) | Low resistance | Midrange resistance | Height resistance | Latent resistance | Total (%) |
Therapy | DDI | 27 | 19 (70.37) | 1 | 1 | 6 | 0 | 8 (29.63) |
 | D4T | 27 | 24 (88.89) | 2 | 1 | 0 | 0 | 3 (11.11) |
 | EFV | 27 | 15 (55.56) | 0 | 1 | 9 | 2 | 12 (44.44) |
 | NVP | 27 | 16 (59.26) | 0 | 0 | 10 | 1 | 11 (40.74) |
No therapy | DDI | 68 | 66 (97.06) | 1 | 0 | 0 | 3 | 4 (5.88) |
 | D4T | 68 | 68 (100.00) | 1 | 0 | 0 | 4 | 5 (7.35) |
 | EFV | 68 | 65 (95.58) | 1 | 2 | 0 | 0 | 3 (4.41) |
 | NVP | 68 | 65 (95.58) | 1 | 2 | 1 | 0 | 3 (4.41) |